14 results
424B4
BGLC
BioNexus Gene Lab Corp
21 Jul 23
Prospectus supplement with pricing info
3:37pm
competitive advantage lies in our turnaround time, expert interpretation, and easy-to-understand reports with timely clinical decision-making … management experience that qualifies him as an “audit committee financial expert” as defined by the rules and regulations of the SEC.
Compensation
10-K
ap90jeog2xjgnp
31 Mar 20
Annual report
1:12pm
S-1/A
gomtes
25 Feb 19
IPO registration (amended)
3:30pm
S-1
q9m4a936jp
29 Jan 19
IPO registration
12:00am
S-1
EX-5
7fkns0th
29 Jan 19
IPO registration
12:00am
- Prev
- 1
- Next